A company based in Texas has recalled a coffee product after a substance found in a drug used to treat erectile dysfunction was found in the product, the Food and Drug Administration (FDA) confirmed. Bestherbs Coffee LLC has recalled all of its “New of Kopi Jantan Tradisional Herbs Coffee” after the FDA said it found...
NYS Entity Status
NYS Filing Date
FEBRUARY 05, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - DIAMOND BASE, LLC
AROUND THE WEB
- Coffee recalled for containing Viagra-like ingredient
By Fox News - Thursday Jul 20, 2017
- Calvin Harris to perform at Rihanna's Diamond Ball charity
By MESFIN FEKADU, AP Music Writer - Wednesday Aug 16, 2017
NEW YORK (AP) — The writer and producer of Rihanna's hit "We Found Love" is set to perform at her charity event in New York next month.Rihanna said Wednesday that Scottish DJ-producer Calvin Harris will join fellow performer Kendrick Lamar and host Dave Chappelle on Sept. 14 for her third Diamond Ball.
- Diamonds just got even more valuable
By News.com.au - Monday Jul 3, 2017
Diamonds just got much more valuable. Thanks to Australian research, they will soon become “lenses” offering a powerful view of individual molecules and atoms. The ability to do this is at the heart of modern drug and materials research. But current techniques rely on very large and power hungry devices that offer an averaged impression...
- Dan Loeb buys a chunk of Nestle, blasts ‘staid’ culture
By Carleton English - Monday Jun 26, 2017
Dan Loeb just placed his biggest bet ever on a chocolate company. The activist investor’s hedge fund Third Point LLC amassed a $3.5 billion stake in Nestle, the world’s largest packaged foods company, representing roughly 1.25 percent of the Swiss-based company’s shares. Loeb is hoping to reinvigorate the brand amid changing food tastes as well...
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]